期刊文献+

缺血后处理对肝硬化大鼠肝脏缺血-再灌注损伤保护作用的免疫机制 被引量:5

Immunity mechanism of ischemia postconditioning in preventing from hepatic ischemia-reperfusion injury in liver cirrhotic rats
原文传递
导出
摘要 目的探讨缺血后处理(IPO)对肝硬化大鼠肝脏缺血-再灌注损伤(IRI)的保护作用及其免疫机制。方法按随机数字表法将30只肝硬化模型SD大鼠随机分为IPO组、IRI组和单纯肝切除组(肝切组),各10只。IPO组先切除40%肝脏,阻断第一肝门20 min,然后反复缺血-再灌注3次,最后持续再灌注;IRI组,切除40%肝脏,阻断第一肝门20 min后持续再灌注;肝切组切除40%肝脏。分别于术后6、24 h抽取大鼠下腔静脉血,检测ALT、AST、分化群(CD)4+、CD8+、调节性T细胞(Treg)百分率、白细胞介素(IL)-4、IL-10水平。3组比较采用单因素方差分析,两两比较采用LSD-t检验。结果恢复灌注6 h后,IPO组的ALT、AST分别为(1 623±378)、(1 993±469)U/L,IRI组相应为(2 690±549)、(3 020±577)U/L,IPO组ALT、AST明显低于IRI组(LSD-t=-4.21,-3.72;P<0.05)。恢复灌注24 h后,IPO组的ALT、AST分别为(307±76)、(555±137)U/L,IRI组相应为(518±105)、(1 050±355)U/L,IPO组ALT、AST亦明显低于IRI组(LSD-t=-4.06,-3.37;P<0.05)。恢复灌注6 h后,IPO组CD4+、CD8+、CD4+/CD8+比值、Treg、IL-4、IL-10分别为(57±5)%、(25±3)%、2.3±0.5、(8.9±0.4)%、(1.27±0.25)mg/L、(0.61±0.03)mg/L,IRI组相应为(52±6)%、(12±3)%、4.5±0.8、(7.3±0.3)%、(0.66±0.11)mg/L、(0.34±0.06)mg/L,IPO组CD8+、Treg、IL-4、IL-10较IRI组明显升高,CD4+/CD8+比值明显降低(LSD-t=7.74,6.67,5.52,9.31,-6.69;P<0.05)。结论 IPO可能通过减轻免疫损伤发挥对肝硬化大鼠肝脏IRI的保护作用。 ObjectiveTo investigate the protective effects and its mechanism of ischemia postconditioning (IPO) in hepatic ischemia-reperfusion injury (IRI) in liver cirrhotic rats.MethodsThirty liver cirrhotic Sprague-Dawley (SD) rats were randomly divided into three groups according to the random table methods: ischemia postconditioning (IPO) group, IRI group, and pure hepatectomy (PH) group with 10 rats in each group. Rats in IPO group underwent partial hepatectomy (40%), and the first portal was occluded for 20 min, then 3 times of ischemia-reperfusion were performed, and ifnally continuous&nbsp;reperfusion. Rats in IRI group underwent partial hepatectomy (40%), and the ifrst portal was occluded for 20 min, then continuous reperfusion was performed. Rats in PH group underwent partial hepatectomy (40%) only. Inferior vena cava blood was collected at 6, 24 h after operation. Levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), proportion of cluster of differentiation (CD) 4+, CD8+, regulatory T cells (Treg) and levels of interleukin (IL)-4, IL-10 were tested. Comparison of three groups was conducted by one way analysis of variance and pairwise comparison by LSD-t test.ResultsAfter 6 h reperfusion, levels of ALT and AST in IPO group [(1 623±378) , (1 993±469) U/L] were signiifcantly lower than those in IRI group [(2 690±549) , (3 020±577) U/L] (LSD-t=-4.21,-3.72; P〈0.05). After 24 h reperfusion, levels of ALT and AST in IPO group [(307±76) , (555±137) U/L] were still signiifcantly lower than those in IRI group [(518±105) , (1 050±355) U/L] (LSD-t=-4.06,-3.37;P〈0.05). After 6 h reperfusion, proportion of CD4+, CD8+, CD4+/CD8+ ratio, Treg, and levels of IL-4, IL-10 in IPO group were (57±5) %, (25±3) %, 2.3±0.5, (8.9±0.4) %, (1.27±0.25) mg/L, (0.61±0.03) mg/L, respectively. While in IRI group, they were (52±6)%, (12±3) %, 4.5±0.8, (7.3±0.3) %, (0.66±0.11) mg/L, (0.34±0.06) mg/L, respectively. In IPO group, CD8+, Treg, IL-4 and IL-10 increased signiifcantly, while CD4+/CD8+ ratio decreased signiifcantly, compared with those in IRI group (LSD-t= 7.74, 6.67, 5.52, 9.31,-6.69;P〈0.05).ConclusionIPO can prevent from hepatic IRI injury in liver cirrhotic rats through decreasing the immune injury.
出处 《中华肝脏外科手术学电子杂志》 CAS 2014年第6期36-39,共4页 Chinese Journal of Hepatic Surgery(Electronic Edition)
基金 国家自然科学基金(81201918) 广东省自然科学基金(10151008901000113)
关键词 再灌注损伤 大鼠 肝硬化 实验性 缺血后处理 T淋巴细胞亚群 白细胞介素4 白细胞介素10 Reperfusion injury Rats Liver cirrhosis,experimental Ischemic postconditioning T-lymphocyte subsets Interleukin-4 Interleukin-10
  • 相关文献

参考文献20

  • 1Theodoraki K, Arkadopoulos N, Nastos C, et al. Small liver remnants are more vulnerable to ischemia/reperfusion injury after extended hepatectomies: a case-control study[J]. World J Surg, 2012, 36(12):2895-2900.
  • 2Akhtar MZ, Henderson T, Sutherland A, et al. Novel approaches to preventing ischemia-reperfusion injury during liver transplantation[J]. Transplant Proc, 2013, 45(6):2083-2092.
  • 3Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, et al. Factors in the pathophysiology of the liver ischemia-reperfusion injury[J]. J Surg Res, 2008, 147(1):153-159.
  • 4Linfert D, Chowdhry T, Rabb H. Lymphocytes and ischemia- reperfusion injury[J]. Transplant Rev, 2009, 23(1):1-10.
  • 5Yang X, Bai H, Wang Y, et al. Deletion of regulatory T cells supports the development of intestinal ischemia-reperfusion injuries[J]. J Surg Res, 2013, 184(2):832-837.
  • 6Zhao ZQ, Corvera .IS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning[J]. Am J Physiol Heart Circ Physiol, 2003, 285(2):H579-588.
  • 7van den Akker EK, Manintveld OC, Hesselink DA, et al. Protection against renal ischemia-reperfusion injury by ischemic postconditioning[J]. Transplantation, 2013, 95(11 ): 1299-1305.
  • 8Lintz JA, Dalio MB, Joviliano EE, et al. Ischemic pre and postconditioning in skeletal muscle injury produced by ischemia and reperfusion in rats[J]. Acta Cir Bras, 2013, 28(6):441-446.
  • 9Liu J, Xu Q, Wang H, et al. Neuroprotection of ischemic postconditioning by downregulating the postsynaptic signaling mediated by kainate receptors[J]. Stroke, 2013, 44(7):2031-2035.
  • 10Lin HC, Lee TK, Tsai CC, et al. Ischemic postconditioning protects liver from ischemia-reperfusion injury by modulating mitochondrial permeability transition[J]. Transplantation, 2012, 93(3):265-271.

二级参考文献29

  • 1马毅,华赟鹏,陈祖兵,张晋昕.大鼠肝癌模型的化学诱导及肝癌肝移植模型的建立[J].中华医学杂志,2006,86(12):850-853. 被引量:6
  • 2郑敏,陈聪,赵雅萍,吴娟丽.探讨大鼠肝硬化动物模型的建立方法[J].肝胆外科杂志,2006,14(2):136-137. 被引量:15
  • 3林洪远,管向东,周立新,艾宇航,王可富.乌司他丁、α1胸腺肽联合治疗严重脓毒症——一种新的免疫调理治疗方法的临床研究[J].中华医学杂志,2007,87(7):451-457. 被引量:99
  • 4吴孟超 杨广顺.大鼠肝硬化模型的研究[J].中华实验外科杂志,1984,1:145-145.
  • 5Cichoz-Lach H, Celifiski K, Stomka M, et al. Pathophysiology of portal hypertension [J]. J Physiol Pharmacol, 2008, 59 (Soppl 2) : 231-238.
  • 6Pinzani M, Vizzutti F. Fibrosis and cirrhosis reversibility: clinical features and implications [J]. Clin Liver Dis, 2008, 12(4) : 901-913.
  • 7LalemanW, Nevens F. Cirrhotic portM hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding[J]. Minerva Med, 2006,97(4): 325-345.
  • 8Singh NA, Reau N. Management of hepatitis B virus [J]. J Antimicrob Chemother, 2008, 62(2):224-228.
  • 9Vanheule E, Geerts AM, Van Huysse J, etal. An intravital microscopic study of the hepatic microcirculation in cirrhotic mice models: relationship between fibrosis and angiogenesis [J]. Int J ExpPathol, 2008, 89(6):419-432.
  • 10Jaramillo-Judrez F, Rodriguez Vdzquez ML, Rincon-Sanchez AR, et al. Acute renal failure induced by carbon tetrachloride in rats with hepatic cirrhosis [J]. Ann Hepatol, 2008, 7(4): 331 338.

共引文献7

同被引文献45

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部